Qiu 2000.
Methods |
Study design: randomized controlled trial, parallel group Unit of analysis: eyes Number randomized: 92 in total, 48 to the MMC group, 44 to the DCR alone group Number of arms: 2 Enrollment start year: 1995 Length of follow‐up: 29 months Sample size calculations: not reported Losses to follow‐up: none |
|
Participants |
Country: China Age (mean (SD)): 29.6 (NR) in total Females (n (%)): 82 (89) in total Inclusion criteria: patients with chronic dacryocystitis Exclusion criteria: patients with upper lacrimal duct or nasal disorders, other systemic disorders Study group differences: no difference |
|
Interventions |
Intervention: DCR with application of 0.4 mg/mL MMC Comparison intervention: DCR alone |
|
Outcomes |
Measured outcomes:
Adverse events: anastomotic bleeding |
|
Identification |
Author name: SK Qiu
Institution: Department of Ophthalmology, Tengzhou Central Hospital Email: not reported |
|
Notes |
Funding source: not reported Declarations of interest: not reported Trial registration number: not reported |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Random sequence generation was not reported. |
Allocation concealment (selection bias) | Unclear risk | Method of treatment allocation concealment was not reported. |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Masking of study participants and investigators was not reported. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Masking of outcome assessors was not reported. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No missing data, participants were analyzed in the group to which they had been randomized. |
Selective reporting (reporting bias) | Unclear risk | No trial or protocol registration available for comparison to ascertain selective outcome reporting. |
Other bias | Unclear risk | There was insufficient information to permit a judgement of 'low risk' or 'high risk'. |